CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-09 | Oelschlager Kristen M Chief Operating Officer | Option exercise | +15,961 | 150,965 | ||
| 2024-12-09 | Oelschlager Kristen M Chief Operating Officer | Shares withheld for taxes | −4,206 | $30.91 | $130K | 146,759 |
| 2024-12-09 | Oelschlager Kristen M Chief Operating Officer | Option exercise · Restricted Stock Units | −15,961 | 31,922 | ||
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,972 | $31.35 | $62K | 85,748 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,010 | $31.35 | $32K | 73,606 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −948 | $31.35 | $30K | 62,943 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −300 | $31.35 | $9K | 5,860 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $31.35 | $9K | 5,852 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $31.35 | $9K | 5,852 |
| 2024-12-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −299 | $31.35 | $9K | 5,852 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −4,669 | $30.95 | $145K | 10,382 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,326 | $30.95 | $41K | 2,949 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,326 | $30.95 | $41K | 2,949 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −348 | $31.32 | $11K | 10,034 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −99 | $31.32 | $3K | 2,850 |
| 2024-12-03 | BRADBURY DANIEL Director | Sale 10b5-1 | −99 | $31.32 | $3K | 2,850 |
| 2024-11-15 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −6,123 | $29.87 | $183K | 31,623 |
| 2024-11-15 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −800 | $30.40 | $24K | 30,823 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,972 | $34.15 | $67K | 87,720 |
| 2024-11-12 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,010 | $34.15 | $34K | 74,616 |
Page 31 of 45 · 897 trades